GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, KDR, MET, MIF, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, SLC1A1, SRC, TERT, XDH |
10.596 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, HMGCR, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
9.69647 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
8.87426 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
8.75661 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTAFR, PTGS2, SRC, TYR |
8.5176 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
8.09342 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, HMGCR, MIF, PIK3CA, PIM1, PPARA, PTAFR, PTGS1, PTGS2, TYR, XDH |
7.85806 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, GSK3B, HCAR2, HMGCR, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
7.43026 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, GSK3B, HCAR2, HMGCR, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
7.42375 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
7.42305 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTAFR, PTGS2, SRC, TYR |
7.42305 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
7.16085 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.16085 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.16085 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, GSK3B, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTAFR, PTGS2, SRC, TERT, TYR |
6.98185 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.7464 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
6.7464 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HMGCR, HSD17B1, HSD17B2 |
6.73384 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
6.64489 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, HMGCR, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.58444 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
6.49634 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FLT3, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
6.40549 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF, PTGS1, PTGS2 |
6.40549 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, GSK3B, HMGCR, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.23034 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SLC1A1, SRC, TERT, XDH |
6.21118 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF, PTGS1, PTGS2 |
6.21118 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, PTAFR, PTGS1, PTGS2, SRC, TERT, XDH |
6.21118 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC |
6.19714 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.16355 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.76202 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
5.74971 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.71942 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, GRM3, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.48064 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, GSK3B, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, SRC, TERT |
5.44223 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.36376 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.34391 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, CSNK2A1, CYP1B1, FLT3, GRM1, GSK3B, HMGCR, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
5.33737 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, IGF1R, KDR, MIF, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, PTPN1, SRC, TERT |
5.28648 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT |
5.28648 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
5.28008 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
5.2274 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5, PTAFR |
5.18335 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.13613 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.13613 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, GSK3B, HMGCR, IGF1R, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
5.12979 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
5.12979 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, GSK3B, HMGCR, IGF1R, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
5.10588 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF, PTGS1, PTGS2 |
5.1033 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.1033 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.1033 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, CYP1B1, FLT3, GRM1, HMGCR, KDR, MET, MIF, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.1033 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, GSK3B, HMGCR, HSD17B2, IGF1R, KDR, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR |
5.09263 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.09263 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PTAFR, PTGS2, SRC, TYR |
5.08606 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, GRM5, GSK3B, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC |
5.08599 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, CSNK2A1, CYP1B1, FABP4, FLT3, GRM1, GSK3B, HMGCR, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
4.95423 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.94313 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.92333 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, ESR1, GRIK5, GRM5, GSK3B, IGF1R, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, SRC |
4.88071 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, ESR1, FLT3, HMGCR, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, PTAFR, PTGS2, TERT |
4.87992 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, SRC, TERT |
4.71001 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.66319 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, GSK3B, IGF1R, KDR, MMP2, PIK3CA, PTAFR, PTGS2, SRC |
4.65741 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.61743 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.53485 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2, TERT |
4.49517 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
4.44933 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, HCAR2, HMGCR, KDR, MIF, PIK3CB, PTGS2, SRC |
4.36861 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, GSK3B, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.36319 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF, PTAFR |
4.34896 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.32599 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
4.19094 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
4.18377 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CYP19A1, GRIK5, GRM5, GSK3B, HCAR2, HMGCR, MIF, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT |
4.15942 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
4.15171 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HMGCR, HSD17B1, HSD17B2 |
4.11188 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, CDC25B, ESR1, FLT3, GRM1, GRM5, GSK3B, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.04647 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PTAFR, PTGS2, SRC, TERT |
3.99836 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.98197 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.97758 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
3.91305 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, PPARA, PTAFR, PTGS2, SRC |
3.91305 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2 |
3.91125 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTAFR, PTGS2, SRC, TYR |
3.81826 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.80988 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, MIF, PIK3CB, PTPN1, SRC |
3.78812 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PTAFR, PTGS2, SRC, TERT |
3.74709 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
3.681 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, GSK3B, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
3.65353 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, HMGCR, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, TERT, TYR |
3.63285 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, NQO2, PTGS1 |
3.62973 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
3.62284 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
3.62284 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, SRC |
3.59544 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, GRM1, HMGCR, MMP2, PPARA, PTAFR, PTGS2, SRC, TERT, TYR |
3.59544 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, SRC, TYR |
3.55127 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
3.53706 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
3.47768 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
3.47609 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR |
3.43384 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PTAFR, PTGS2, SRC, TERT |
3.42785 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTPN1, SRC |
3.42063 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, IGF1R, KDR, MET, MIF, MMP9, PTAFR, PTGS2, SRC, TERT |
3.41829 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.40218 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, FABP3, FLT3, GRM5, GSK3B, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
3.37535 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, CDC25B, ESR1, FLT3, GRM1, GRM5, GSK3B, MET, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TERT, XDH |
3.37535 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.37454 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.33876 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, FLT3, GRM1, HMGCR, KDR, MIF, PIK3CB, PTPN1, SRC, XDH |
3.32845 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
3.31144 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31144 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.31144 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, HMGCR, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.29865 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.28235 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, AURKB, CDC25B, ESR1, FLT3, GRM1, GRM5, GSK3B, MIF, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TERT, XDH |
3.26883 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.26883 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, CDC25B, ESR1, FABP3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
3.25374 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, MET, MIF, PIK3CB, PIM1, SRC, TYR |
3.24896 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AURKB, CDC25B, CSNK2A1, ESR1, FABP3, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
3.22708 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
3.22708 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB |
3.22592 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, XDH |
3.21206 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGS1, PTGS2 |
3.18688 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, MIF, PIK3CB |
3.16423 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.15092 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.15092 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, ESR1, FABP4, GSK3B, HMGCR, IGF1R, MET, MIF, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.15092 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
3.13385 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGS2, SRC |
3.12216 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, FABP3, FLT3, GRM5, GSK3B, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
3.12136 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PTPN1, SRC |
3.09808 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.09185 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, MIF, PIK3CA, PIK3CB, PTAFR, PTGS1, PTGS2 |
3.09185 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, FABP4, FLT3, GRM1, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
3.09185 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, TYR, XDH |
3.07798 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, HMGCR, MIF, PTAFR, PTGS1, PTGS2 |
3.06734 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, CSNK2A1, CYP2D6, ESR1, FABP4, GRM3, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.04331 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.03562 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
3.03562 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
3.03562 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, GRM3, GRM8, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.03562 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, GSK3B, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT |
2.97762 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, CYP2D6, GSK3B, MET, MMP9, PPARA, SRC, TERT |
2.96926 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.96926 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.95397 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, KDR, MIF, PIK3CB, PTPN1, SRC, XDH |
2.95397 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GRM5, GSK3B, IGF1R, PPARA, PTGS2, SRC |
2.92317 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
MIF, MMP9, PTGS2, PTPN1, SRC |
2.92184 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, FABP3, HMGCR, KDR, PTAFR, PTGS2, SRC |
2.86008 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.81643 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, GRIK5, GSK3B, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.80783 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.79752 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.79623 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.78813 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
2.78203 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CYP1B1, GRIK5, GSK3B, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.78203 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, MIF, PIK3CB, PTPN1, SRC |
2.77823 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.74872 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.72135 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, GRM3, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.72135 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRM1, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
2.71814 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, CA2, CYP1B1, ESR1, GRM1, GSK3B, HCAR2, HMGCR, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PTAFR, PTGS2, SLC1A1, SRC, TERT, XDH |
2.70846 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.70532 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.68992 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, MIF, PIK3CB, PTPN1, SRC |
2.68004 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.65618 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.65357 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, PTAFR, PTGS2, SRC |
2.62937 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.62503 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.61191 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ESR1, GSK3B, HMGCR, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.61191 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.61104 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.6092 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ESR1, GSK3B, HMGCR, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.6086 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, ESR1, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, PIK3CA, PIK3CB, PTAFR, SRC |
2.60678 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.58692 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58692 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, XDH |
2.57912 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.57298 |
[BP] GO:0010942 |
positive regulation of cell death
|
CYP1B1, GRIK5, GSK3B, HCAR2, HMGCR, MMP9, PIK3CB, PTGS2, SRC, XDH |
2.5721 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CYP19A1, GSK3B, HCAR2, MIF, PTAFR, PTGS2, SRC, TERT |
2.5708 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, ESR1, GSK3B, HMGCR, IGF1R, MET, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.56712 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.56712 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.56712 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.51011 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.51011 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, HMGCR, PTAFR, TYR |
2.50136 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.49876 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
IGF1R, PIK3CA, PIK3CB, PTAFR |
2.49876 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.49783 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.49369 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, ESR1, FLT3, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.48033 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.46358 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.4614 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.45045 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, HCAR2, HMGCR, KDR, MET, MIF, MMP9, PIM1, PTAFR, PTGS2, SLC1A1, SRC, TERT |
2.43631 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
IGF1R, PIK3CA, PIK3CB, PTAFR |
2.43009 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC, XDH |
2.4284 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
MIF, MMP9, PTGS2, PTPN1, SRC, TERT |
2.4284 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, GRM5, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.42166 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41354 |
[BP] GO:0010038 |
response to metal ion
|
CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2, TERT |
2.36725 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35984 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.34638 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.34638 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34638 |
[BP] GO:0030335 |
positive regulation of cell migration
|
IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
2.33656 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT, XDH |
2.32881 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.3245 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.3245 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
2.29005 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, HCAR2, PIK3CB, PTGS2 |
2.28731 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.27723 |
[BP] GO:0006693 |
None
|
MIF, PTGS1, PTGS2 |
2.27723 |
[BP] GO:0006692 |
None
|
MIF, PTGS1, PTGS2 |
2.27723 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AURKB, CSNK2A1, CYP2D6, ESR1, FABP4, GRM3, GRM8, GSK3B, HMGCR, IGF1R, MET, MIF, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.25956 |
[BP] GO:2000147 |
positive regulation of cell motility
|
IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
2.2492 |
[BP] GO:0050730 |
None
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.2489 |
[BP] GO:0007568 |
aging
|
AURKB, CYP1A1, HMGCR, MIF, PTGS2, TERT |
2.2489 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
GRM5, GSK3B, IGF1R |
2.23747 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, GSK3B, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TERT, XDH |
2.23747 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.20768 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GRM1, GRM5, GSK3B, HMGCR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.19572 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.19572 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
HCAR2, MIF, PIK3CB |
2.19572 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
2.17836 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.17575 |
[BP] GO:0008217 |
None
|
ADORA1, PPARA, PTAFR, PTGS1, PTGS2 |
2.16344 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, MIF, PIK3CB, PTPN1, SRC |
2.15822 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, SRC |
2.15822 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
MIF, PTGS1, PTGS2 |
2.15822 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC |
2.13002 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.12075 |
[BP] GO:1904645 |
response to amyloid-beta
|
GRM5, GSK3B, IGF1R |
2.12075 |
[BP] GO:0070542 |
None
|
FABP3, PTAFR, PTGS2, SRC |
2.1204 |
[BP] GO:1901570 |
None
|
ALOX5, MIF, PTGS1, PTGS2 |
2.1204 |
[BP] GO:0051100 |
negative regulation of binding
|
AURKB, CYP2D6, GSK3B, MET, PPARA |
2.10022 |
[BP] GO:0003018 |
None
|
ADORA1, HMGCR, PTAFR, PTGS2, SRC |
2.10022 |
[BP] GO:0040017 |
positive regulation of locomotion
|
IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC, TERT |
2.09377 |
[BP] GO:0007188 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.08995 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.089 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, FABP4, HMGCR, KDR, MET, MIF, PPARA, PTGS2 |
2.07227 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
MIF, MMP9, PTGS2, PTPN1, SRC |
2.07103 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.05423 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.05423 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2 |
2.04931 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, GSK3B, HSD17B2, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
2.03476 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, PTAFR, TYR |
2.03476 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.03476 |
[BP] GO:0033029 |
regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.03476 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.03476 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.03476 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
GSK3B, HMGCR, IGF1R, MET, MIF, PTGS2, PTPN1, TERT, XDH |
2.00643 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTPN1, SLC1A1, SRC, TERT |
4.94588 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, TYR |
4.44933 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
4.36879 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.63285 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B2, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TYR |
3.31144 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, GSK3B, SRC |
3.0537 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA4, CA9, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTGS2, SLC1A1, SRC |
2.65202 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
2.6092 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.60197 |
[CC] GO:0014069 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55497 |
[CC] GO:0099572 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55497 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, SLC1A1 |
2.27723 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, CA1, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GSK3B, HMGCR, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
2.2703 |
[CC] GO:0098794 |
None
|
ADORA1, GRIA2, GRIA4, GRM3, GSK3B |
2.13002 |
[CC] GO:0005783 |
None
|
ADORA1, CA4, CYP19A1, CYP2D6, FLT3, GRIK5, HMGCR, KDR, PTGS2, PTPN1, XDH |
2.08434 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
2.03558 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.03476 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.92829 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, TYR, XDH |
8.89273 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.40277 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FLT3, GSK3B, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
7.98534 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, TYR, XDH |
7.49366 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.58444 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.5445 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.76778 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
5.57754 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.44223 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, SRC |
5.36376 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.23188 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
5.12979 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS1, PTGS2, TYR |
5.1033 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR |
4.65874 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FLT3, GSK3B, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
4.61743 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.22526 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
4.00928 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR |
3.98097 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
3.92868 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PTAFR |
3.84949 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PTAFR |
3.84949 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR |
3.81613 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1 |
3.80988 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.63285 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.59785 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, PTAFR |
3.47119 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2, XDH |
3.27102 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.27059 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, TERT, TYR, XDH |
3.26883 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
3.25248 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.22708 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.22105 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SLC1A1, TERT, TYR, XDH |
3.0242 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.97045 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC, TERT |
2.97045 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.96926 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.70652 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.68992 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, SLC1A1, SRC, XDH |
2.68965 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, CSNK2A1, ESR1, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MIF, MMP9, NQO2, PTGS2, TERT, TYR, XDH |
2.67877 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.67877 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.6092 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.6092 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.58692 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.56712 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2 |
2.55027 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.34638 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.31998 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PTAFR, SLC1A1, SRC, XDH |
2.12864 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.089 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, NQO2 |
2.03647 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03476 |